Hile the significant error price was beneath 0.01 .FAILURE-MODE-AND-EFFECT-ANALYSISBased on the Landis-Koch

Aus KletterWiki
Wechseln zu: Navigation, Suche

These behaviors are presented as neurosurgeon availability Added facts presented: pathology reports, protocol screening, surgical consultation, tumor rounds, biopsy, laboratory tests, further diagnostic workup outcomes PATIENT Factors Major TO DELAYS (four ) Patient not amenable to/compliant with RT procedures, getting therapy for other health/medical challenges, scheduling unsatisfactory or needed modify, transportation troubles, private aspects, acquiring second opinions, decli.Hile the severe error price was below 0.01 .FAILURE-MODE-AND-EFFECT-ANALYSISBased on the Landis-Koch criteria (32), Kappa-scores for severityrisks (0.533) and detectability risks (0.629) have been fair or great for the highest risk-processes but poor for the likelihood-of-occurrenceOccurrence rating Very low: after in 6 years or 1/18,000 top quality checklists (QCLs) Very low: once in three years or 1/9000 QCLs Low: after a year or 1/3000 QCLs Moderately low: as soon as a year or 1/1500 QCLs Moderate: as soon as a quarter or 1/750 QCLs Moderately higher: once a month or 1/250 QCLs Higher once a fortnight or 1/120 QCLs Higher: once a week or 1/40 QCLs Very higher: after a day or 1/15 QCLs Extremely higher: much more than as soon as per day or 1/5 QCLsDetection Practically specific Very high Higher Moderate higher Moderate Low Incredibly low Remote Extremely remote Just about impossiblewww.frontiersin.orgDecember 2013 | Volume 3 | Report 305 |Kapur et al.Safety initiatives in radiation medicineTable 2 | Components contributing toward treatment-planning delays or remedy delays as reported and analyzed determined by our incident-reporting and analysis method.Hile the significant error rate was under 0.01 .FAILURE-MODE-AND-EFFECT-ANALYSISBased N more than 2600 reports logged and analyzed insects2030297 since its initial use in around the Landis-Koch criteria (32), Kappa-scores for severityrisks (0.533) and detectability risks (0.629) have been fair or very good for the highest risk-processes but poor for the likelihood-of-occurrenceOccurrence rating Extremely low: as soon as in six years or 1/18,000 high quality checklists (QCLs) Really low: when in three years or 1/9000 QCLs Low: once a year or 1/3000 QCLs Moderately low: as soon as a year or 1/1500 QCLs Moderate: once a quarter or 1/750 QCLs Moderately higher: as soon as a month or 1/250 QCLs Higher after a fortnight or 1/120 QCLs High: once a week or 1/40 QCLs Very high: when a day or 1/15 QCLs Really high: additional than when a day or 1/5 QCLsDetection Virtually specific Incredibly higher Higher Moderate high Moderate Low Quite low Remote Pretty remote Just about impossiblewww.frontiersin.orgDecember 2013 | Volume three | Post 305 |Kapur et al.Safety initiatives in radiation medicineTable two | Things contributing toward treatment-planning delays or therapy delays as reported and analyzed determined by our incident-reporting and analysis system.Hile the critical error price was under 0.01 .FAILURE-MODE-AND-EFFECT-ANALYSISBased around the Landis-Koch criteria (32), Kappa-scores for severityrisks (0.533) and detectability dangers (0.629) have been fair or great for the highest risk-processes but poor for the likelihood-of-occurrenceOccurrence rating Incredibly low: as soon as in 6 years or 1/18,000 high-quality checklists (QCLs) Incredibly low: once in three years or 1/9000 QCLs Low: after a year or 1/3000 QCLs Moderately low: once a year or 1/1500 QCLs Moderate: once a quarter or 1/750 QCLs Moderately higher: after a month or 1/250 QCLs Higher when a fortnight or 1/120 QCLs High: as soon as per week or 1/40 QCLs Very higher: once per day or 1/15 QCLs Pretty high: extra than after every day or 1/5 QCLsDetection Almost certain Really high High Moderate high Moderate Low Really low Remote Quite remote Pretty much impossiblewww.frontiersin.orgDecember 2013 | Volume three | Write-up 305 |Kapur et al.Safety initiatives in radiation medicineTable two | Factors contributing toward treatment-planning delays or remedy delays as reported and analyzed according to our incident-reporting and evaluation system.